0
Startups & Venture·November 17, 2026·1 min read

Isomorphic Labs raises $5bn from Sequoia and Greenoaks for AI drug design

Share

A $5B Series C just six months after a $2.1B raise puts Isomorphic Labs in a different league—AI drug discovery is being capitalized like a platform, not a biotech experiment. Pharma operators should assume these models will be strategic counterparties, not just tools, within this decade.